Knoll Capital Management as of Sept. 30, 2016
Portfolio Holdings for Knoll Capital Management
Knoll Capital Management holds 18 positions in its portfolio as reported in the September 2016 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Corbus Pharmaceuticals Hldgs | 29.3 | $17M | 2.6M | 6.52 | |
| Abeona Therapeutics | 14.1 | $8.0M | 1.4M | 5.91 | |
| Synthetic Biologics | 11.6 | $6.6M | 3.7M | 1.77 | |
| Vascular Biogenics | 7.7 | $4.4M | 861k | 5.12 | |
| Cempra | 7.6 | $4.3M | 181k | 23.88 | |
| Advaxis | 5.0 | $2.9M | 275k | 10.39 | |
| Alcobra | 4.9 | $2.8M | 1.1M | 2.51 | |
| Volitionrx (VNRX) | 4.5 | $2.6M | 462k | 5.58 | |
| Ampio Pharmaceuticals | 3.6 | $2.1M | 2.7M | 0.76 | |
| Newlink Genetics Corporation | 2.6 | $1.5M | 102k | 14.68 | |
| Aldeyra Therapeutics (ALDX) | 1.8 | $1.0M | 136k | 7.64 | |
| Keryx Biopharmaceuticals | 1.8 | $1.0M | 200k | 5.15 | |
| Ritter Pharmaceuticals | 1.5 | $869k | 527k | 1.65 | |
| Advaxis Inc. w exp 07/15/201 | 1.3 | $750k | 113k | 6.67 | |
| Ohr Pharmaceutical | 1.0 | $568k | 205k | 2.77 | |
| Bio Blast Pharma | 0.7 | $424k | 251k | 1.69 | |
| Caladrius Biosciences | 0.5 | $266k | 56k | 4.77 | |
| Champions Oncology (CSBR) | 0.3 | $184k | 111k | 1.66 |
